Article
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.
Nature reviews. Endocrinology - 1 Aug 2018
Mantovani Giovanna, Bastepe Murat, Monk David, de Sanctis Luisa, Thiele Susanne, Usardi Alessia, Ahmed S Faisal, Bufo Roberto, Choplin Timothée, De Filippo Gianpaolo, Devernois Guillemette, Eggermann Thomas, Elli Francesca M, Freson Kathleen, García Ramirez Aurora, Germain-Lee Emily L, Groussin Lionel, Hamdy Neveen, Hanna Patrick, Hiort Olaf, Jüppner Harald, Kamenický Peter, Knight Nina, Kottler Marie-Laure, Le Norcy Elvire, Lecumberri Beatriz, Levine Michael A, Mäkitie Outi, Martin Regina, Martos-Moreno Gabriel Ángel, Minagawa Masanori, Murray Philip, Pereda Arrate, Pignolo Robert, Rejnmark Lars, Rodado Rebecca, Rothenbuhler Anya, Saraff Vrinda, Shoemaker Ashley H, Shore Eileen M, Silve Caroline, Turan Serap, Woods Philip, Zillikens M Carola, Perez de Nanclares Guiomar, Linglart Agnès
Abstract excerpt
This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset obesity and ectopic ossifications, as well as endocrine defects that often include resistance to parathyroid hormone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.